Received Oct 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | F7X23 | — |
patients received a Hepatitis A that have been expired; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 3-year-old male patient who received HAV (Havrix) (batch number F7X23, expiry date 25-MAY-2023) for prophylaxis. On 06-JUN-2023, the patient received the 1st dose of Havrix. On 06-JUN-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: patients received a Hepatitis A that have been expired). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-OCT-2025 The reporter was just calling wanted to see per manufacture if there were any recommendations or confirmed regarding that.